0001193125-16-465945.txt : 20160217 0001193125-16-465945.hdr.sgml : 20160217 20160216210731 ACCESSION NUMBER: 0001193125-16-465945 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160217 DATE AS OF CHANGE: 20160216 GROUP MEMBERS: BDF IV ANNEX FUND, LP GROUP MEMBERS: BIOASIA INVESTMENTS IV, LLC GROUP MEMBERS: BIOASIA MANAGEMENT, LLC GROUP MEMBERS: BIOTECHNOLOGY DEVELOPMENT FUND II, LP GROUP MEMBERS: BIOTECHNOLOGY DEVELOPMENT FUND IV AFFILIATES, LP GROUP MEMBERS: BIOTECHNOLOGY DEVELOPMENT FUND IV, LP GROUP MEMBERS: VIVO VENTURES FUND V, LP GROUP MEMBERS: VIVO VENTURES V AFFILIATES FUND, LP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Capnia, Inc. CENTRAL INDEX KEY: 0001484565 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88637 FILM NUMBER: 161431385 BUSINESS ADDRESS: STREET 1: 1235 RADIO ROAD STREET 2: SUITE 110 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-213-8444 MAIL ADDRESS: STREET 1: 1235 RADIO ROAD STREET 2: SUITE 110 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Vivo Ventures V, LLC CENTRAL INDEX KEY: 0001399028 IRS NUMBER: 841663511 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 575 HIGH STREET, SUITE 201 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 650-688-0818 MAIL ADDRESS: STREET 1: 575 HIGH STREET, SUITE 201 CITY: PALO ALTO STATE: CA ZIP: 94301 SC 13G 1 d143139dsc13g.htm SC 13G SC 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

Capnia, Inc.

(Name of Issuer)

Common stock, par value S0.001 per share

(Title of Class of Securities)

14066L204

(CUSIP Number)

December 31, 2015

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-l(b)

¨ Rule 13d-l(c)

x Rule 13d-I(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing infonnation which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

SCHEDULE 13G

CUSIP No.14006L204

 

  1   

Names of Reporting Persons

 

Bioasia Management, LLC

  2  

Check the appropriate box if a member of a Group (see instructions)

 

(a)  ¨        (b)  ¨

  3  

Sec Use Only

 

  4  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

    5    

Sole Voting Power

 

   6   

Shared Voting Power

 

56,744

   7   

Sole Dispositive Power

 

   8   

Shared Dispositive Power

 

56,744

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

56,744

10  

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

 

¨

11  

Percent of class represented by amount in row (9)

 

0.4%

12  

Type of Reporting Person (See Instructions)

 

OO

 

Page 2 of 15

SCHEDULE 13G

CUSIP No.14006L204

 

  1   

Names of Reporting Persons

 

Biotechnology Development Fund II, LP

  2  

Check the appropriate box if a member of a Group (see instructions)

 

(a)  ¨        (b)  ¨

  3  

Sec Use Only

 

  4  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

    5    

Sole Voting Power

 

   6   

Shared Voting Power

 

56,744

   7   

Sole Dispositive Power

 

   8   

Shared Dispositive Power

 

56,744

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

56,744

10  

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

 

¨

11  

Percent of class represented by amount in row (9)

 

0.4%

12  

Type of Reporting Person (See Instructions)

 

PN

 

Page 3 of 15

SCHEDULE 13G

CUSIP No.14006L204

 

  1   

Names of Reporting Persons

 

BioAsia Investments IV, LLC

  2  

Check the appropriate box if a member of a Group (see instructions)

 

(a)  ¨        (b)  ¨

  3  

Sec Use Only

 

  4  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

    5    

Sole Voting Power

 

   6   

Shared Voting Power

 

402,108

   7   

Sole Dispositive Power

 

   8   

Shared Dispositive Power

 

402,108

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

402,108

10  

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

 

¨

11  

Percent of class represented by amount in row (9)

 

2.9%

12  

Type of Reporting Person (See Instructions)

 

OO

 

Page 4 of 15

SCHEDULE 13G

CUSIP No.14006L204

 

  1   

Names of Reporting Persons

 

Biotechnology Development Fund IV, LP

  2  

Check the appropriate box if a member of a Group (see instructions)

 

(a)  ¨        (b)  ¨

  3  

Sec Use Only

 

  4  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

    5    

Sole Voting Power

 

   6   

Shared Voting Power

 

167,742

   7   

Sole Dispositive Power

 

   8   

Shared Dispositive Power

 

167,742

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

167,742

10  

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

 

¨

11  

Percent of class represented by amount in row (9)

 

1.2%

12  

Type of Reporting Person (See Instructions)

 

PN

 

Page 5 of 15

SCHEDULE 13G

CUSIP No.14006L204

 

  1   

Names of Reporting Persons

 

Biotechnology Development Fund IV Affiliates, LP

  2  

Check the appropriate box if a member of a Group (see instructions)

 

(a)  ¨        (b)  ¨

  3  

Sec Use Only

 

  4  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

    5    

Sole Voting Power

 

   6   

Shared Voting Power

 

3,093

   7   

Sole Dispositive Power

 

   8   

Shared Dispositive Power

 

3,093

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

3,093

10  

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

 

¨

11  

Percent of class represented by amount in row (9)

 

.02%

12  

Type of Reporting Person (See Instructions)

 

PN

 

Page 6 of 15

SCHEDULE 13G

CUSIP No.14006L204

 

  1   

Names of Reporting Persons

 

BDF IV Annex Fund, LP

  2  

Check the appropriate box if a member of a Group (see instructions)

 

(a)  ¨        (b)  ¨

  3  

Sec Use Only

 

  4  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

    5    

Sole Voting Power

 

   6   

Shared Voting Power

 

231,273

   7   

Sole Dispositive Power

 

   8   

Shared Dispositive Power

 

231,273

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

231,273

10  

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

 

¨

11  

Percent of class represented by amount in row (9)

 

1.6%

12  

Type of Reporting Person (See Instructions)

 

PN

 

Page 7 of 15

SCHEDULE 13G

CUSIP No.14006L204

 

  1   

Names of Reporting Persons

 

Vivo Ventures V, LLC

  2  

Check the appropriate box if a member of a Group (see instructions)

 

(a)  ¨        (b)  ¨

  3  

Sec Use Only

 

  4  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

    5    

Sole Voting Power

 

   6   

Shared Voting Power

 

7,903,090

   7   

Sole Dispositive Power

 

   8   

Shared Dispositive Power

 

7,903,090

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

7,903,090

10  

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

 

¨

11  

Percent of class represented by amount in row (9)

 

51.4%

12  

Type of Reporting Person (See Instructions)

 

OO

 

Page 8 of 15

SCHEDULE 13G

CUSIP No.14006L204

 

  1   

Names of Reporting Persons

 

Vivo Ventures Fund V, LP

  2  

Check the appropriate box if a member of a Group (see instructions)

 

(a)  ¨        (b)  ¨

  3  

Sec Use Only

 

  4  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

    5    

Sole Voting Power

 

   6   

Shared Voting Power

 

7,811,423

   7   

Sole Dispositive Power

 

   8   

Shared Dispositive Power

 

7,811,423

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

7,811,423

10  

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

 

¨

11  

Percent of class represented by amount in row (9)

 

50.8%

12  

Type of Reporting Person (See Instructions)

 

PN

 

Page 9 of 15

SCHEDULE 13G

CUSIP No.14006L204

 

  1   

Names of Reporting Persons

 

Vivo Ventures V Affiliates Fund, LP

  2  

Check the appropriate box if a member of a Group (see instructions)

 

(a)  ¨        (b)  ¨

  3  

Sec Use Only

 

  4  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

    5    

Sole Voting Power

 

   6   

Shared Voting Power

 

91,667

   7   

Sole Dispositive Power

 

   8   

Shared Dispositive Power

 

91,667

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

91,667

10  

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

 

¨

11  

Percent of class represented by amount in row (9)

 

0.7%

12  

Type of Reporting Person (See Instructions)

 

PN

 

Page 10 of 15

Item 1.

 

(a) Name of Issuer: Capnia, Inc.

 

(b) Address of Issuer’s Principal Executive Offices:

1235 Radio Road, Suite 110

Redwood City, CA 94065

 

Item 2.

 

(a) Name of Person Filing:

The names of the reporting persons are:

BioAsia Management, LLC

Biotechnology Development Fund II, LP

BioAsia Investments IV, LLC

Biotechnology Development Fund IV, LP

Biotechnology Development Fund IV Affiliates, LP

BDF IV Annex Fund, LP

Vivo Ventures V, LLC

Vivo Ventures Fund V, LP

Vivo Ventures V Affiliates Fund, LP

 

(b) Address of Principal Business Office or, if None, Residence:

575 High Street, Suite 201

Palo Alto, CA 94301

 

(c) Citizenship:

Delaware

 

(d) Title and Class of Securities:

Common stock, par value $0.001 per share

 

(e) CUSIP No.: 14006L204

 

Item 3. If this statement is filed pursuant to §§ 240.lJd-l(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)    ¨    Broker or dealer registered under Section 15 of the Act;
(b)    ¨    Bank as defined in Section 3(aX6) of the Act;
(c)    ¨    Insurance company as defined in Section 3(aXI 9) of the Act;
(d)    ¨    Investment company registered under Section 8 of the Investment Company Act of 1940;
(e)    ¨    An investment adviser in accordance with Rule 13d-l(b)( I XiiXE);
(f)    ¨    An employee benefit plan or endowment fund in accordance with Rule 13d-l(b)( l )(ii)(F);
(g)    ¨    A parent holding company or control person in accordance with Rule 13d-l(b)( l)(ii)(G);
(h)    ¨    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 u.s.c. 1813);
(i)    ¨    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
(j)    ¨    A non-U.S.institution in accordance with Rule 240.13d-l (b)(l )(ii)(J );
(k)    ¨    Group, in accordance with Rule 240.13d-l (b)(l )(ii)(K). If filing as a non-U .S. institution in accodance with Rule 240.13d-l (b)( l)(ii)(J), please specify the type of institution:

 

Page 11 of 15

Item 4. Ownership

 

(a) Amount Beneficially Owned:

BioAsia Management LLC, as the general partner of Biotechnology Development Fund II, L.P., may be deemed to beneficially own 56,744 shares of Common Stock of the Issuer, representing approximately 0.4% of the 14,017,909 shares of common stock outstanding as of December 31, 2015 (the “Outstanding Shares”).

BioAsia Investments IV LLC, as the general partner of each of Biotechnology Development Fund IV, L.P., Biotechnology Development Fund IV Affiliates, L.P., and BDF IV Annex Fund, L.P., may be deemed to beneficially own 402,108 shares of Stock of the Issuer, representing approximately 2.9% of the Outstanding Shares. The amount consists of 396,884 shares of common stock and 5,224 shares of common stock receivable upon conversion of 2012 warrant stock. As of December 31, 2015, Biotechnology Development Fund IV, L.P. held 167,742 shares of stock of the Issuer, representing approximately 1.2% of the Outstanding shares, Biotechnology Development Fund IV Affiliates, L.P. held 3,093 shares of stock of the Issuer, representing approximately 0.02% of the Outstanding Shares, and BDF IV Annex Fund, L.P. held 231,273 shares of stock of the Issuer, representing approximately 1.6% of the Outstanding Shares.

Vivo Ventures Fund V, LLC, as the general partner of each of Vivo Ventures Fund V, L.P. and Vivo Ventures V Affiliates Fund, L.P., may be deemed to beneficially own 7,903,090 shares of Stock of the Issuer, representing approximately 51.4% of the Outstanding Shares as of December 31, 2015. The amount consists of 6,533,345 shares of common stock, 352,893 shares of common stock receivable upon conversion of 2014 warrant stock, 325,887 shares of common stock receivable upon conversion of 2012 warrant stock, 590,965 shares of common stock receivable upon conversion of warrant A stock, and 100,000 shares of common stock receivable upon conversion of warrant B stock. As of December 31, 2015, Vivo Ventures Fund V, L.P. held 7,811,423 shares of stock of the Issuer, representing approximately 50.8% of the Outstanding Shares, and Vivo Ventures V Affiliates Fund, L.P. held 91,667 shares of stock of the Issuer, representing approximately 0.7% of the Outstanding Shares.

Each of Biotechnology Development Fund II, L.P., Biotechnology Development Fund IV, L.P., Biotechnology Development Fund IV Affiliates, L.P., BDF lV Annex Fund, L.P., Vivo Ventures Fund V, L.P. and Vivo Ventures V Affiliates Fund, L.P. is referred to herein as a “Fund” and each of BioAsia Management LLC, BioAsia Investments IV LLC, and Vivo Ventures Fund V, LLC is referred to herein as a “General Partner.” Each of the Funds disclaims beneficial ownership of the shares of Common Stock owned by any other Fund. Each of the General Partners disclaims beneficial ownership of the shares of Common Stock owned by any Fund for which it is not a General Partner and any shares of Common Stock beneficially owned by the other General Partners.

 

Page 12 of 15

(b) Percent of Class:

See Item 11 of each cover page, which is based on Item 9 of the respective cover page. See also Item 4(a) above.

 

(c) Number of shares as to which such person has:

 

  (i) Sole power to vote or to direct the vote:

 

       See Item 5 of each cover page.

 

  (ii) Shared power to vote or to direct the vote:

 

       See Item 6 of each cover page.

 

  (iii) Sole power to dispose or to direct the disposition of:

 

       See Item 7 of each cover page.

 

  (iv) Shared power to dispose or to direct the disposition of:

 

       See Item 8 of each cover page.

 

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   ¨.

Not applicable.

 

Item 6. Ownership of more than Five Percent on Behalf of Another Person.

Not applicable.

 

Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

Not applicable.

 

Item 8. Identification and classification of members of the group.

Not applicable.

 

Item 9. Notice of Dissolution of Group.

Not applicable.

 

Item 10. Certifications.

Not applicable.

 

Page 13 of 15

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: 2/16/16

 

BioAsia Management, LLC
By:  

/s/ Frank Kung

Name: Frank Kung
Title: Managing Member

 

Biotechnology Development Fund II, L.P.
By:  

/s/ Frank Kung

Name: Frank Kung

Title: Managing Member of BioAsia Management, LLC; General Partner of Biotechnology Development Fund II, L.P.

 

BioAsia Investments IV LLC
By:  

/s/ Frank Kung

Name: Frank Kung
Title: Managing Member
Biotechnology Development Fund IV, L.P.
By:  

/s/ Frank Kung

Name: Frank Kung

Title: Managing Member of BioAsia Investments IV, LLC; General Partner of Biotechnology Development Fund IV, L.P.

Biotechnology Development Fund IV Affiliates, L.P.

By:  

/s/ Frank Kung

Name: Frank Kung

Title: Managing Member of BioAsia Investments IV, LLC; General Partner of Biotechnology Development Fund IV Affiliates, L.P.

 

BDF IV Annex Fund, L.P.
By:  

/s/ Frank Kung

Name: Frank Kung

Title: Managing Member of BioAsia Investments IV, LLC; General Partner of BDF IV Annex Fund, L.P.

 

Vivo Ventures Fund V, LLC
By:  

/s/ Frank Kung

Name: Frank Kung
Title: Managing Member

 

Vivo Ventures Fund V, L.P.
By:  

/s/ Frank Kung

Name: Frank Kung

Title: Managing Member of Vivo Ventures Fund V, LLC; General Partner of Vivo Ventures Fund V, L.P.

 

Page 14 of 15

Vivo Ventures V Affiliates Fund, L.P.
By:   /s/ Frank Kung
Name: Frank Kung

Title: Managing Member of Vivo Ventures Fund V, LLC; General Partner of Vivo Ventures V Affiliates Fund, L.P.

 

Page 15 of 15